Series B Round
Funding Details
NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome, aiming to extend human healthspan. The company focuses on developing age-reversing therapies, particularly targeting liver diseases through innovative mRNA technology. Founded by Brian Armstrong, NewLimit is at the forefront of anti-aging biotechnology, leveraging cutting-edge research to create transformative therapies. The company aims to push its liver-rejuvenating mRNA medicine into clinical trials with the new funding. This funding round will enable NewLimit to accelerate its research and development efforts, bringing its innovative therapies closer to market. The Series B funding will also support the expansion of NewLimit's research team and enhance its laboratory capabilities. The investment is expected to significantly advance the company's mission to revolutionize the treatment of age-related diseases.
Confidence Score
Participating Investors
Kleiner Perkins is a leading American venture capital firm that specializes in investing in incubation, early-stage, and growth-stage companies across...
Nathaniel Dourif Friedman is an American technology executive and investor, known for his role as the CEO of GitHub. He has a strong background in tec...
Daniel Gross is a prominent angel investor and technology entrepreneur, known for his work in the AI sector and as a co-founder of several successful ...
Khosla Ventures is a private American venture capital firm that focuses on providing early-stage and growth-stage funding to technology-driven compani...
A venture capital firm focused on investing in innovative startups that leverage human capital and technology to drive growth and efficiency.
Dimension is a first-of-its-kind firm partnering with founders at the interface of technology and life sciences to transform the trajectory of life on...
Founders Fund is a San Francisco-based venture capital firm investing in companies building revolutionary technologies. The firm is known for its cont...
Kleiner Perkins is a leading American venture capital firm that has been at the forefront of technology investments for over five decades, partnering ...
Co-founder and CEO of Coinbase, a leading cryptocurrency exchange. Brian Armstrong is a prominent advocate for economic freedom through cryptocurrency...
Human Protocol is a decentralized identity project focused on building a zero-knowledge identity solution that enhances digital identity and financial...
Related Tweets
No tweets found for this funding round.